Treating epilepsy in pregnant women

Bibliography

• Vajda FJE, Horgan D, Hollingworth S, et al. The prescribing of antiepileptic drugs for pregnant Australian women. Aust NZ J Obstet Gynaecol 2011;52:49-53
   PubMedGoogle Scholar
• Bobo WV, Davis RL, Toh S, et al. Trends in the use of antiepileptic drugs among pregnant women in the US, 2001-2007: a medication exposure in pregnancy risk evaluation study. Paediatr Perinat Epidemiol 2012;26:578-88
   PubMedGoogle Scholar
• Man S-L, Petersen I, Thompson M, Nazareth I. Antiepileptic drugs during pregnancy in primary care: a UK population based study. PLoS One 2012;7:e52339
   PubMedGoogle Scholar
• Knight AH, Rhind EG. Epilepsy and pregnancy: a study of 153 pregnancies in 59 patients. Epilepsia 1975;16:99-110
   PubMed Web of Science ®Google Scholar
• Schmidt D. The effect of pregnancy on the natural history of epilepsy: review of the literature. In: Janz D, Bossi L, Dam M, Helge H, Richens A, Schmidt D, editors, Epilepsy, pregnancy, and the child. Raven Press, New York; 1982. p. 3-14
   Google Scholar
• Locock C. Discussion following Dr Sieveking `Analysis of fifty-two cases of epilepsy observed by the author'. Med Times Gazette 1857;1:524-6
   Google Scholar
• Mygind KI, Dam M, Christiansen J. Phenytoin and phenobarbitone plasma clearance during pregnancy. Acta Neurol Scand 1976;54:160-6
   PubMed Web of Science ®Google Scholar
• Lander CM, Edwards VE, Eadie MJ, Tyrer JH. Plasma anticonvulsant concentrations during pregnancy. Neurology 1977;27:128-31
   PubMed Web of Science ®Google Scholar
• Pirie DAJ, Al Watter BH, Pirie AM, et al. Effect of monitoring strategies on seizures in pregnant women on lamotrigine: a meta-analysis. Eur J Obstet Gynecol Reprod Biol 2013. Available from: http://dx.doi.org/10.1016/j.ejogrb.2013.10.021
   PubMedGoogle Scholar
• Harden C, Hopp J, Ting TY, et al. Management issues for women with epilepsy - focus on pregnancy (an evidence-based review): 1. Obstetrical complications and changes in seizure frequency. Epilepsia 2009;50:1229-36
   PubMed Web of Science ®Google Scholar
• Pennell P. Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology 2003;61(Suppl 2):S35-42
   PubMedGoogle Scholar
• Lopez-Fraile IP, Cid AO, Juste AO, Modrego PJ. Levetiracetam plasma level monitoring during pregnancy, delivery, and postpartum: clinical and outcome implications. Epilepsy Behav 2009;15:372-5
   PubMedGoogle Scholar
• Tomson T, Landmark CJ, Battino D. Antiepileptic drug treatment in pregnancy: changes in drug disposition and their clinical implications. Epilepsia 2013;54:405-14
   PubMed Web of Science ®Google Scholar
• Reisinger TL, Newman M, Loring DW, et al. Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy. Epilepsy Behav 2013;20:13-18
   Google Scholar
• Sabers A, Petrenaite V. Seizure frequency in pregnant women treated with lamotrigine monotherapy. Epilepsia 2009;50:2163-6
   PubMedGoogle Scholar
• Patsalos PN, Berry DJ, Bourgeois BFD, et al. Antiepileptic drugs - best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission in therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 2008;49:1239-76
   PubMed Web of Science ®Google Scholar
• Pennell PB, Klein AM, Browning N, et al. Differential effects of antiepileptic drugs on neonatal outcomes. Epilepsy Behav 2012;24:449-56
   PubMed Web of Science ®Google Scholar
• Artamo M, Gissler M, Malm H, et al. Effect of maternal epilepsy and antiepileptic drug use during pregnancy on perinatal health in offspring. Nationwide, retrospective cohort study in Finland. Drug Saf 2013;36:359-69
   PubMedGoogle Scholar
• Rauchenzauner M, Ehrensberger M, Prieschl M, et al. Generalized tonic-clonic seizures and antiepileptic drugs during pregnancy - a matter of importance for the baby? J Neurol 2013;260:484-8
   PubMed Web of Science ®Google Scholar
• Holst AG, Winkel BG, Risgaard B, et al. Epilepsy and risk of death and sudden unexpected death in the young. A nationwide study. Epilepsia 2013;54:1613-20
   PubMed Web of Science ®Google Scholar
• Meadow SR. Congenital abnormalities and anticonvulsant drugs. Proc R Soc Med 1970;63:48-9
   PubMedGoogle Scholar
• Hill DS, Wlodarczyk BJ, Palacios AM, Finnell RH. Teratogenic effects of antiepileptic drugs. Expert Rev Neurother 2010;10:943-59
   PubMed Web of Science ®Google Scholar
• Tomson T, Battino D. Teratogenic effects of antiepileptic drugs. Lancet Neurol 2012;11:803-13
   PubMed Web of Science ®Google Scholar
• Wlodarczyk BJ, Palacios AM, George TM, Finnell RH. Antiepileptic drugs and pregnancy outcomes. Am J Med Genet A 2012;158A:2071-90
   PubMed Web of Science ®Google Scholar
• Molgaard-Nielsen D, Hviid A. Newer-generation antiepileptic drugs and the risk of major birth defects. J Am Med Assoc 2011;305:1996-2002
   PubMed Web of Science ®Google Scholar
• Werler M, Ahrens KA, Bosco JLF, et al. Use of antiepileptic medications in pregnancy in relation to risk of birth defects. Ann Epidemiol 2011;21:842-50
   PubMedGoogle Scholar
• Hernandez-Diaz S, Smith CR, Shen A, et al. Comparative study of antiepileptic drugs during pregnancy. Neurology 2012;78:1692-9
   PubMed Web of Science ®Google Scholar
• Cassina M, Dilaghi A, Di Gianantonio E, et al. Pregnancy outcome in women exposed to antiepileptic drugs: teratogenic role of maternal epilepsy and its pharmacologic treatment. Reprod Toxicol 2013;39:50-7
   PubMedGoogle Scholar
• Vajda FE, O'Brien TJ, Hitchcock A, et al. Critical relationship between sodium valproate dose and human teratogenesis: results of the Australian register of anti-epileptic drugs in pregnancy. J Clin Neurosci 2004;11:854-8
   PubMed Web of Science ®Google Scholar
• Tomson T, Battino D, Bonizzoni E, et al. Dose-dependent risk of malformation with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011;10:609-17
   PubMed Web of Science ®Google Scholar
• Vajda FJE, O'Brien TJ, Graham J, et al. Dose-dependency of fetal malformations associated with valproate. Neurology 2013;81:999-1003
   PubMedGoogle Scholar
• Vajda FJE, O'Brien TJ, Graham J, et al. Associations between particular types of fetal malformation and antiepileptic drug exposure in utero. Acta Neurol Scand 2013;128:228-34
   PubMed Web of Science ®Google Scholar
• Morrow J, Russell A, Guthrie E, et al. Malformation risk of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006;77:193-8
   PubMed Web of Science ®Google Scholar
• Vajda FJE, Graham JE, Hitchcock AA, et al. Is lamotrigine a significant human teratogen? Observations from the Australian Pregnancy Register. Seizure 2010;19:558-61
   PubMed Web of Science ®Google Scholar
• Vajda FJE, Graham J, Roten A, et al. Teratogenicity of the newer antiepileptic drugs - the Australian experience. J Clin Neurosci 2012;19:57-9
   PubMed Web of Science ®Google Scholar
• Vajda FJE, Hitchcock A, Graham J, et al. The teratogenic risk of antiepileptic drug polytherapy. Epilepsia 2010;51:805-10
   PubMed Web of Science ®Google Scholar
• Mawwer G, Briggs M, Baker GA, et al. Pregnancy with epilepsy: obstetric and neonatal outcome of a controlled study. Seizure 2010;19:112-19
   PubMedGoogle Scholar
• Holmes LB, Mittendorf R, Shen A, et al. Fetal effects of anticonvulsant polytherapies. Arch Neurol 2011;68:1275-81
   PubMed Web of Science ®Google Scholar
• Mahwinney E, Craig J, Morrow J, et al. Levetiracetam in pregnancy. Results from the UK and Ireland epilepsy and pregnancy registers. Neurology 2013;80:401-5
   Google Scholar
• Montouris G. Safety of the newer antiepileptic drug oxcarbazepine during pregnancy. Curr Med Res Opin 2005;21:693-701
   PubMed Web of Science ®Google Scholar
• Fujii H, Goel A, Bernard N, et al. Pregnancy outcomes following gabapentin use. Results of a prospective comparative study. Neurology 2013;80:1565-70
   PubMed Web of Science ®Google Scholar
• Adab N, Kini U, Ayres J, et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2004;75:1575-83
   PubMed Web of Science ®Google Scholar
• Vinten J, Adab N, Kini U, et al. Neuropsychological effects of exposure to anticonvulsant medication in utero. Neurology 2005;64:949-54
   PubMed Web of Science ®Google Scholar
• Meador KJ, Baker GA, Browning N, et al. Cognitive function at 3 years after fetal exposure to antiepileptic drugs. N Engl J Med 2009;360:1587-605
   Google Scholar
• Bromley RL, Leeman BA, Baker GA, Meador KJ. Cognitive and developmental effects of antiepileptic drugs. Epilepsy Behav 2011;22:9-16
   PubMedGoogle Scholar
• Bromley RL, Mawer GE, Briggs M, et al. The prevalence of neurodevelopmental disorders in children exposed prenatally to antiepileptic drugs. J Neurol Neurosurg Psychiatry 2013;84:637-43
   PubMed Web of Science ®Google Scholar
• Veiby G, Daltvelt AK, Schjelberg S, et al. Exposure to antiepileptic drugs in utero and child development: a prospective population-based study. Epilepsia 2013;54:1462-72
   PubMed Web of Science ®Google Scholar
• Cummings C, Stewart M, Stevenson M, et al. Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine. Arch Dis Child 2011;96:643-7
   PubMed Web of Science ®Google Scholar
• Meador KJ, Baker GA, Browning N, et al. Effect of fetal antiepileptic drug exposure: outcomes at age 4.5 years. Neurology 2012;78:1207-14
   PubMed Web of Science ®Google Scholar
• Meador KJ, Baker GA, Browning N, et al. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol 2013;12:244-52
   PubMed Web of Science ®Google Scholar
• Christensen J, Gronborg TK, Sorensen MJ, et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. J Am Med Assoc 2013;309:1696-703
   PubMed Web of Science ®Google Scholar
• Cohen MJ, Meador KJ, Browning N, et al. Fetal antiepileptic drug exposure: adaptive and emotional/behavioral functioning at 6 years. Epilepsy Behav 2013;29:308-15
   PubMed Web of Science ®Google Scholar
• Veiby G, Engelsen BA, Gilhus NE. Early child development and exposure to antiepileptic drugs prenatally and through breastfeeding. A prospective cohort study on children of women with epilepsy. JAMA Neurol 2013;70:1367-74
   PubMed Web of Science ®Google Scholar
• Hunt S, Russell A, Smithson WH, et al. Topiramate in pregnancy. Preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology 2008;71:272-6
   PubMed Web of Science ®Google Scholar
• Holmes LB, Hernandez-Diaz S. Newer anticonvulsants: lamotrigine, topiramate and gabapentin. Birth Defects Res A 2012;94:599-606
   PubMed Web of Science ®Google Scholar
• Margulis AV, Mitchell AA, Gilboa SM, et al. Use of topiramate in pregnancy and risk of oral clefts. Am J Obstet Gynecol 2012;207:292; 405.e1-7
   PubMedGoogle Scholar
• Green MW, Seeger JD, Peterson C, Bhattacharyya A. Utilization of topiramate during pregnancy and risk of birth defects. Headache 2012;52:1070-84
   PubMed Web of Science ®Google Scholar
• Matalon S, Schectman S, Goldzweig G, Ornoy A. The teratogenic effect of carbamazepine: a meta-analysis of 1255 exposures. Reprod Toxicol 2002;16:9-17
   PubMed Web of Science ®Google Scholar
• Campbell E, Devenney E, Morrow J, et al. Recurrence risk of congenital malformations in infants exposed to antiepileptic drugs in utero. Epilepsia 2013;54:165-71
   PubMed Web of Science ®Google Scholar
• Vajda FJE, O'Brien TJ, Lander CM, et al. Tetratogenesis in repeated pregnancies in antiepileptic drug-treated women. Epilepsia 2013;54:181-6
   PubMed Web of Science ®Google Scholar
• Begum S, Sarma SP, Thomas SV. Malformation in index pregnancy in women with epilepsy is not followed by recurrence in subsequent pregnancy. Epilepsia 2013;54:e163-7
   Google Scholar
• Shallcross R, Bromley RL, Irwin B, et al. Child development following in utero exposure: levetiracetam vs sodium valproate. Neurology 2011;76:383-9
   PubMed Web of Science ®Google Scholar
• Vajda FJE, Hitchcock A, Graham J, et al. Seizure control in antiepileptic drug-treated pregnancy. Epilepsia 2008;49:172-5
   PubMed Web of Science ®Google Scholar
• Moore JL, Aggarwal P. Lamotrigine use in pregnancy. Expert Opin Pharmacother 2012;13:1213-16
   PubMed Web of Science ®Google Scholar
• Berkovic SF, Scheffer IE. Genetics of human partial epilepsy. Curr Opin Neurol 1997;10:110-14
   PubMedGoogle Scholar
• Battino D, Tomson T, Bonizzoni E, et al. Seizure control and treatment changes in pregnancy: observations from the EURAP epilepsy pregnancy registry. Epilepsia 2013;54:1621-7
   PubMed Web of Science ®Google Scholar
• Thomas SV, Syam U, Devi JS. Predictors of seizures during pregnancy in women with epilepsy. Epilepsia 2012;53:e85-8
   PubMed Web of Science ®Google Scholar
• Eadie MJ, Tyrer JH. Anticonvulsant therapy: pharmacological basis and practice. 3rd edition. Churchill-Livingstone, Edinburgh; 1989
   Google Scholar
• Yerby M. Management issues for women with epilepsy: neural tube defects and folic acid supplementation. Neurology 2003;61(Suppl 2):S23-6
   Google Scholar
• Lindhout D. Antiepileptic drugs during pregnancy and cognitive outcomes. Lancet Neurol 2013;13:219-20
   Google Scholar
• Shorvon SD, Tomson T, Cock HR. The management of epilepsy during pregnancy - progress is painfully slow. Epilepsia 2009;50:973-4
   PubMedGoogle Scholar
• Levy RH, Mattson RH, Meldrum BH, Perucca E, editors. Antiepileptic drugs. 5th edition. Lippincott Williams & Wilkins, Philadelphia; 2002
   Google Scholar
• Shorvon SD, Perucca E, Fish DR, Dodson WE, editors. The treatment of epilepsy. 2nd edition. Blackwell Science, Oxford; 2004
   Google Scholar
• Tomson T, Palm R, Kallen K, et al. Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation. Epilepsia 2007;48:1111-16
   PubMed Web of Science ®Google Scholar
• Davanzo R, Bo SD, Bua J, et al. Antiepileptic drugs and breastfeeding. Ital J Pediatr 2013;39:50
   PubMed Web of Science ®Google Scholar